Buy Celecoxib

Celecoxib

Celecoxib: Pain Relief Pill Overview

Celecoxib is a prescription medication belonging to the non-steroidal anti-inflammatory drug (NSAID) class, specifically a selective cyclo-oxygenase-2 (COX-2) inhibitor. It is marketed as a pill and is available in strengths of 100 mg and 200 mg. In Hong Kong, celecoxib is regulated by the Department of Health’s Pharmacy and Poisons Office and is only supplied with a physician’s prescription.

How Celecoxib Works in the Body

Celecoxib selectively blocks the COX-2 enzyme, which is primarily responsible for producing prostaglandins that mediate inflammation, pain, and fever. By inhibiting COX-2 while sparing COX-1, celecoxib reduces inflammatory prostaglandins without markedly affecting the protective prostaglandins in the stomach lining.

• Onset of action: pain relief can begin within 1-2 hours after oral intake.
• Peak plasma concentration: typically reached 2-3 hours after a dose.
• Duration: therapeutic effects generally last 8-12 hours, allowing once-daily dosing for most indications.

Celecoxib is well absorbed from the gastrointestinal tract, with an oral bioavailability of about 22-40 % that increases when taken with food. It is metabolized mainly by the liver enzyme CYP2C9 and eliminated through the kidneys and bile.

Conditions Treated with Celecoxib

Celecoxib is approved in Hong Kong for the following indications:

• Osteoarthritis (pain and inflammation of joints)
• Rheumatoid arthritis (symptom control when combined with disease-modifying agents)
• Ankylosing spondylitis (pain and stiffness of the spine)
• Acute mild-to-moderate pain (post-operative, dental, musculoskeletal)
• Primary dysmenorrhea (menstrual pain)

These uses are based on extensive clinical trial data demonstrating efficacy comparable to traditional NSAIDs with a lower risk of gastrointestinal ulceration when taken at recommended doses.

Off-Label and Investigational Applications

Evidence from peer-reviewed studies indicates that celecoxib has been explored for:

• Colorectal cancer chemoprevention - several randomized trials have examined low-dose celecoxib, but the cardiovascular risk profile limits routine use.
• Alzheimer’s disease - early-phase studies suggested potential anti-inflammatory benefits, yet larger trials have not confirmed clinical relevance.

Both applications are not approved by Hong Kong health authorities and would require careful medical supervision. Off-label use carries the same safety considerations as approved indications.

Who Should (Not) Use Celecoxib?

Ideal Candidates

• Adults with inflammatory joint conditions who need effective analgesia but have a moderate risk of gastrointestinal complications.
• Patients who can be monitored for blood pressure and cardiovascular health.

Absolute Contraindications

• Known hypersensitivity to celecoxib or any component of the formulation.
• History of myocardial infarction, stroke, or established coronary artery disease; celecoxib may increase the risk of serious cardiovascular events.
• Active gastrointestinal ulceration or bleeding.
• Severe hepatic impairment (Child-Pugh class C).
• Pregnancy in the third trimester (risk of fetal cardiovascular toxicity).

Relative Contraindications

• Controlled hypertension - requires blood pressure monitoring.
• Moderate renal impairment (eGFR 30-59 mL/min/1.73 m²) - dose adjustment may be needed.
• Asthma triggered by NSAIDs - use with caution.
• Concurrent use of other NSAIDs or anticoagulants - increases bleeding risk.

Special populations such as the elderly often require lower starting doses and closer monitoring for renal and cardiovascular side effects.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Gastrointestinal upset (nausea, dyspepsia, abdominal pain) - reported by many patients; usually mild and transient.
• Headache - occurs in a small but noticeable proportion of users.
• Dizziness - may affect balance; advise caution when driving.
• Peripheral edema - swelling of ankles or feet, often dose-related.

Serious Adverse Events

• Cardiovascular events - increased risk of heart attack or stroke, particularly at doses ≥200 mg daily or in patients with existing heart disease.
• Serious gastrointestinal bleeding - rare but possible; any sudden abdominal pain or vomiting of blood warrants emergency care.
• Renal impairment - reduced kidney function may appear after prolonged therapy, especially in patients with baseline renal disease.
• Severe skin reactions such as Stevens-Johnson syndrome - immediate discontinuation and urgent medical attention required.

Drug Interactions

• Anticoagulants (e.g., warfarin, direct oral anticoagulants): additive bleeding risk; closer INR monitoring advised.
• Other NSAIDs or aspirin: heightened gastrointestinal toxicity; avoid concurrent use unless medically necessary.
• ACE inhibitors, ARBs, or diuretics: may reduce renal perfusion; monitor serum creatinine and electrolytes.
• Lithium: NSAIDs can increase lithium levels - check serum lithium concentrations regularly.
• Methotrexate: celecoxib can raise methotrexate concentrations; dose adjustments may be required.

These interactions are primarily mediated through CYP2C9 inhibition or pharmacodynamic synergy affecting hemostasis and renal function.

Food and Lifestyle Interactions

• Food: taking the pill with a meal can lessen stomach irritation without affecting efficacy.
• Alcohol: moderate consumption is permissible, but excessive intake increases gastrointestinal bleed risk.
• Driving: dizziness or visual disturbances may impair driving; avoid operating machinery until you know how the medication affects you.

Patients should disclose all prescription drugs, over-the-counter medications, herbal products, and dietary supplements to their healthcare provider before starting celecoxib.

How to Take Celecoxib

• Standard dosing for acute pain: 100 mg taken once daily; a second 100 mg dose may be added after 6-12 hours if needed, not exceeding 200 mg per day.
• Arthritis and ankylosing spondylitis: 200 mg taken once daily (or 100 mg twice daily) as directed by the prescriber.

Special Population Adjustments

• Elderly (≥75 years): start with 100 mg daily; increase only if benefits outweigh risks.
• Renal impairment (eGFR 30-59 mL/min): 100 mg once daily is generally recommended; avoid if eGFR <30 mL/min.
• Hepatic impairment: use the lowest effective dose; avoid in severe liver disease.

Administration Tips

• Swallow the pill whole with a full glass of water.
• Do not crush, chew, or split the tablet unless a specific lower-strength formulation is prescribed.
• If a dose is missed, take it as soon as remembered unless the next scheduled dose is near; do not double up.

Overdose Management

• Symptoms may include severe stomach pain, nausea, vomiting, or dizziness.
• Seek emergency medical care; treatment is supportive and may involve activated charcoal if presentation is early.

Discontinuation

• Celecoxib can be stopped without tapering in most patients, but abrupt cessation after long-term use may unmask underlying pain.
• For patients on high doses or with cardiovascular risk, a gradual dose reduction under medical supervision may be prudent.

Monitoring and Follow-Up

• Blood pressure: check at baseline and periodically, especially in patients with hypertension.
• Renal function: serum creatinine and eGFR should be assessed before initiation and during prolonged therapy.
• Liver enzymes: monitor if the patient has pre-existing liver disease or if signs of hepatotoxicity develop.
• Signs of GI bleeding: educate patients to report black stools, coffee-ground vomitus, or unexplained anemia.

Routine follow-up visits allow the prescriber to evaluate benefit-risk balance and adjust dosing if necessary.

Storage and Handling

• Store celecoxib tablets at room temperature (15-30 °C), away from excess moisture and direct sunlight.
• Keep the medication in its original container with the lid tightly closed.
• Do not use the product after the expiration date printed on the packaging.
• Dispose of unused tablets according to local pharmacy take-back programs or Hong Kong Waste Disposal Ordinance guidelines; keep out of reach of children.

Medication-Specific Glossary

COX-2 (Cyclo-oxygenase-2)

An enzyme that produces prostaglandins involved in inflammation and pain; selective inhibition reduces inflammation with less impact on stomach lining.

NSAID (Non-steroidal Anti-inflammatory Drug)

A class of medications that relieve pain and inflammation by inhibiting cyclo-oxygenase enzymes.

Cardiovascular Risk

The probability of experiencing heart-related events such as myocardial infarction or stroke; certain NSAIDs, including celecoxib at higher doses, can elevate this risk.

Pharmacokinetics

The study of how a drug is absorbed, distributed, metabolized, and eliminated from the body.

Bioavailability

The proportion of the administered dose that reaches systemic circulation in an active form.

Medical Disclaimer

This article provides educational information about celecoxib and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.